Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias – assessment of clinical outcome, post induction, end of treatment and minimal residual disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.